CDT today
$0.44-$0.07 (-13.10%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $856500000.00
Key levels
Resistance$750750000.00
Resistance$747000000.00
Support$0.04
Latest news & SEC filings
ProductCDT Equity begins early lab research alongside QIMA Life Sciences
NewsCorvus Capital asks CDT Equity board to add an independent director
All CDT news →About CDT Equity
CDT Equity is a pharmaceutical development company that identifies and advances clinical-stage therapeutic assets, often ones deprioritized by larger drugmakers. It uses solid-form chemistry at its Cambridge facilities and AI-powered analysis through a partnership with Sarborg to find new uses for existing compounds. Its pipeline targets immune and inflammatory conditions, male reproductive health, cancer, skin conditions, rare diseases, and animal health, with assets licensed from AstraZeneca. The company operates a lean model, seeking to license assets to third parties after preclinical testing rather than running late-stage trials itself.
Based on the company's 10-K filed Apr 15, 2026.
Nasdaq · Healthcare
CDT Equity Inc. (CDT)
What Is the Price Target for CDT?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is CDT a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CDT.
Start Free Trial →Is CDT Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
17
Moat Score
NONE
3/9
Piotroski Score
-40.2
Altman Z-Score
What Is Smart Money Doing with CDT?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
UNCHANGED
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Regan Andrew | 10% owner | Buy | 499,616 | - | Oct 23, 2026 |
| Regan Andrew | 10% owner | Buy | 1,347,616 | - | Oct 22, 2026 |
| Regan Andrew | director officer | Buy | 5,436,830 | - | Aug 28, 2026 |
| Regan Andrew | director officer | Sale | 290 | - | Aug 28, 2026 |
| Regan Andrew | director officer 10% owner | Buy | 543,683 | - | Aug 28, 2026 |
| Regan Andrew | director officer 10% owner | Sale | 29 | - | Aug 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CDT Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
98.09%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for CDT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CDT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:01:55 | $0.46 | 1,000 | $$460 | SELL |
| 22:01:15 | $0.46 | 2,000 | $$924 | SELL |
| 21:57:40 | $0.49 | 2,000 | $$977 | BUY |
| 21:56:41 | $0.48 | 1,646 | $$798 | MIDPOINT |
| 21:53:12 | $0.50 | 3,000 | $$1K | BUY |
5 dark pool trades shown · $$5K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CDT Equity Inc. (CDT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CDT — frequently asked questions
What is CDT stock price today?
CDT Equity Inc. (CDT) is at $0.44, down 13.10% (-$0.07) at the Nov 12, 2026 close.
Why is CDT stock moving today?
Latest CDT news — Nov 11, 2026: CDT Equity begins early lab research alongside QIMA Life Sciences · Nov 7, 2026: Corvus Capital asks CDT Equity board to add an independent director
Did CDT beat earnings?
CDT last reported on Aug 12, 2026: EPS -$2.18.
What is CDT's P/E ratio?
CDT trades at a P/E of 0.0 vs a Healthcare average of 17.9.
Does CDT pay a dividend?
Yes. CDT's dividend yield is 157.14%.
What are CDT support and resistance levels?
Support: $0.04. Resistance: $747000000.00, $750750000.00, $751500000.00.
What are insiders doing with CDT?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on CDT?
Nov 11, 2026: CDT Equity begins early lab research alongside QIMA Life Sciences · Nov 7, 2026: Corvus Capital asks CDT Equity board to add an independent director